U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06825949) titled 'A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients' on Jan. 21.
Brief Summary: The goal of this study is to explore the efficacy and safety of hyperbaric oxygen in the neoadjuvant treatment of hormone receptor positive breast cancer patients
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Condition:
Breast Cancers
Intervention:
DEVICE: Hyperbaric oxygen treatment
Patients who meet the inclusion criteria will be enrolled and given hyperbaric oxygen intervention, with a minimum of 5 hyperbaric oxygen treatments per chemot...